National Wealth Management Group’s AbbVie ABBV Stock Holding History

National Wealth Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,168	Closed	-$267K	–	216
2025 Q4	$267K	Buy	+1,168	New	+$266K	0.09%	198
2024 Q2	–	Sell	-5,274	Closed	-$960K	–	131
2024 Q1	$960K	Buy	5,274 +3,511	+199%	+$605K	0.75%	35
2023 Q4	$273K	Buy	1,763 +53	+3%	+$7.73K	0.26%	107
2023 Q3	$255K	Sell	1,710 -4	-0.2%	-$587	0.28%	107
2023 Q2	$256K	Sell	1,714 -9,575	-85%	-$1.4M	0.27%	106
2023 Q1	$1.66M	Buy	11,289 +9,700	+610%	+$1.48M	1.9%	10
2022 Q4	$257K	Sell	1,589 -2,497	-61%	-$383K	0.31%	104
2022 Q3	$548K	Buy	4,086 +2,559	+168%	+$367K	0.71%	32
2022 Q2	$234K	Sell	1,527 -538	-26%	-$82.2K	0.29%	92
2022 Q1	$335K	Buy	2,065 +459	+29%	+$66.7K	0.32%	73
2021 Q4	$218K	Buy	+1,606	New	+$190K	0.2%	112

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

National Wealth Management Group's ABBV Position: Q1 2026 in Review

National Wealth Management Group sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,168 shares — an estimated $267K sold.

National Wealth Management Group first reported a position in ABBV in Q4 2021 and held it in 11 quarters. The position peaked at $1.66M in Q1 2023. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

National Wealth Management Group reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
National Wealth Management Group sold 1,168 AbbVie shares in Q1 2026, an estimated $267K.
National Wealth Management Group first reported a position in AbbVie in Q4 2021 and held it in 11 quarters.
National Wealth Management Group's AbbVie position peaked at $1.66M in Q1 2023.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on National Wealth Management Group's 13F filing for Q1 2026, filed 11 May 2026.